Nanjing Pharmaceutical is a state-owned enterprise. Nanjing Pharmaceutical's full name is Nanjing Pharmaceutical Co., Ltd., Nanjing Pharmaceutical Co., Ltd. was founded in 1951, listed on the Shanghai Stock Exchange in 1996, is China's first listed enterprise in the pharmaceutical distribution industry, with a standardized governance structure. The company's main sponsor Nanjing Pharmaceutical (Group) Company (formerly Nanjing Pharmaceutical Company), is the Nanjing Municipal People's Government Secret Office (51) No. 674 approval and the East China Military Commission, Ministry of Health Department of Health Drugs No. 555 approval of the establishment of the nature of the public enterprise, also known as the Nanjing Public Pharmaceutical Company, the administrative subordinate to the Nanjing Municipal Bureau of Health.
Company Partners
The company signed a strategic cooperation agreement with the world's top 500, leading international pharmacy-led health and beauty care group, UniBeauty, in September 2012, and the strategic cooperation project passed the approval of the Ministry of Commerce and the China Securities Regulatory Commission within 2014 and The strategic cooperation project was approved by the Ministry of Commerce and the China Securities Regulatory Commission in 2014 and the stock issuance was completed.
Company's main business
The company is based on the distribution of pharmaceuticals, pharmaceutical supply chain services business, health retail chain business as the main business, the company has now grown from a regional single enterprise into a trans-regional, conglomerate, network-type mega-corporation, there are nearly 70 molecular companies, the market Covering Suzhou, Anhui, Fujian and other places and part of the cloud, Echuan, etc., the company is the designated unit of drug and equipment reserves in Suzhou, Anhui, Fujian, etc. and the designated unit of drug and equipment reserves of the PLA General Logistics Department and the Navy, and the vice-president of the China Pharmaceutical Business Association.
Company business scope
Licensed Items: Class III medical device leasing; pharmaceutical wholesaling; pharmaceutical retailing; import and export of pharmaceuticals; Class III medical device business; food sales; road cargo transportation (excluding dangerous goods); cosmetic production; Class II value-added telecommunication business (according to the law) Projects subject to approval by the relevant departments before carrying out business activities, the specific business projects subject to the results of the approval) general projects: professional design services; property management; non-residential real estate leasing; small and microbus leasing business services; loading and unloading handling; artificial intelligence hardware sales; intelligent robot sales; intelligent material handling equipment sales; information technology consulting services; technical services, technology development, Technical Consultation, Technical Exchange, Technology Transfer, Technology Promotion; Sales of Specialty Chemical Products (excluding hazardous chemicals); Sales of Chemical Products (excluding licensed chemical products); Wholesale of Sporting Goods and Equipments; Retail of Sporting Goods and Equipments; Sales of Specialized Instruments for Teaching and Learning; Sales of Experimental and Analytical Instruments; Leasing of Class II Medical Devices; Sales of Class I Medical Devices; Sales of Class II Medical Devices; Import and Export of Goods; Information consulting services (excluding licensed information consulting services) and so on.
Honors
April 2022, the Specialty Drugs Team of the First Pharmacy of Nanjing Pharmaceutical Company Limited was awarded the "Nanjing Workers' Pioneer".
In July 2022, the company was ranked 281st in the Fortune China 500 list.
In July 2023, it was ranked 257th in the 2023 Fortune China Top 500 Listed Companies list.
On July 25, 2023, it was listed in the 2023 Fortune China 500 list and ranked 300th.